Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes

References

• TsochatzisEAMeyerTBurroughsAKHepatocellular carcinomaN Engl J Med201236619293
   PubMedGoogle Scholar
• SangiovanniATrioloMIavaroneMMultimodality treatment of hepatocellular carcinoma: how field practice complies with international recommendationsLiver Int20183891624163429791968
   PubMed Web of Science ®Google Scholar
• YinZJinHMaTZhouYYuMJianZA meta-analysis of long-term survival outcomes between surgical resection and radiofrequency ablation in patients with single hepatocellular carcinoma ≤2 cm (BCLC very early stageInt J Surg20185661–67616729723677
   PubMedGoogle Scholar
• IkedaKAraseYKobayashiMSignificance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosisJ Gastroenterol200338986587614569444
   PubMed Web of Science ®Google Scholar
• TaketomiAToshimaTKitagawaDPredictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinomaAnn Surg Oncol201017102740274620411432
   PubMed Web of Science ®Google Scholar
• ShimadaMTakenakaKFujiwaraYDes-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinomaCancer19967810209421008918402
   PubMed Web of Science ®Google Scholar
• EguchiSTakatsukiMHidakaMPredictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resectionWorld J Surg20103451034103820127241
   PubMed Web of Science ®Google Scholar
• CaiSHLuSXLiuLLZhangCZYunJPIncreased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinomaTherap Adv Gastroenterol20171010761771
   PubMed Web of Science ®Google Scholar
• PavlovaNNThompsonCBThe emerging hallmarks of cancer metabolismCell Metab2016231274726771115
   PubMed Web of Science ®Google Scholar
• CaoDSongXCheLBoth de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cellsLiver Int2017371808927264722
   PubMed Web of Science ®Google Scholar
• LiZKangYLipid metabolism fuels cancer’s spreadCell Metab201725222823028178563
   PubMed Web of Science ®Google Scholar
• CalvisiDFWangCHoCIncreased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinomaGastroenterology201114031071108321147110
   PubMed Web of Science ®Google Scholar
• NiemanKMKennyHAPenickaCVAdipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growthNat Med201117111498150322037646
   PubMed Web of Science ®Google Scholar
• O’KeefeSJOgdenJRamjeeGRundJContribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinomaCancer Res1990504122612302153453
   PubMed Web of Science ®Google Scholar
• FuruhashiMOguraMMatsumotoMSerum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophagesSci Rep20177121728303004
   PubMedGoogle Scholar
• HoekstraMStitzingerMvan WanrooijEJMicroarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type dietJ Lipid Res200647102198220716885566
   PubMed Web of Science ®Google Scholar
• Guaita-EsteruelasSGumàJMasanaLBorràsJThe peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5Mol Cell Endocrinol2018462Pt B10711828163102
   PubMedGoogle Scholar
• StorchJThumserAETissue-specific functions in the fatty acid-binding protein familyJ Biol Chem201028543326793268320716527
   PubMed Web of Science ®Google Scholar
• FangLYWongTYChiangWFChenYLFatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinomaJ Oral Pathol Med201039434234820040021
   PubMed Web of Science ®Google Scholar
• WangWChuHJLiangYCFABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancerTumour Biol20163711148731488327644245
   PubMedGoogle Scholar
• OhataTYokooHKamiyamaTFatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transitionCancer Med2017651049106128374947
   PubMed Web of Science ®Google Scholar
• WangSGaoHZhangJYeXStable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinomaSe Pu201735993494029048850
   PubMedGoogle Scholar
• JeongCYHahYSChoBIFatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinomaOncol Rep20122841283129222825302
   PubMed Web of Science ®Google Scholar
• InoueMTakahashiYFujiiTKitagawaMFukusatoTSignificance of downregulation of liver fatty acid-binding protein in hepatocellular carcinomaWorld J Gastroenterol20142046175411755125516669
   PubMed Web of Science ®Google Scholar
• CaiSHLvFFZhangYHJiangYGPengJDynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHBBMC Infect Dis2014148524528480
   PubMed Web of Science ®Google Scholar
• ChenSLLiuLLLuSXHBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasisMol Oncol20171191225-1240-124028580773
   PubMed Web of Science ®Google Scholar
• WuXCaiSLiZPotential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysisVirol J2016136427062520
   PubMed Web of Science ®Google Scholar
• XueXCaiSOuHZhengCWuXHealth-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatmentPatient Prefer Adherence201711859328138226
   PubMed Web of Science ®Google Scholar
• CaiSOuZLiuDRisk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndromeUnited European Gastroenterol J201864558566
   PubMed Web of Science ®Google Scholar
• OuHCaiSLiuYXiaMPengJA noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis BTherap Adv Gastroenterol2017102207217
   PubMed Web of Science ®Google Scholar
• ZengJCaiSLiuJXueXWuXZhengCDynamic changes in liver stiffness measured by transient elastography predict clinical outcomes among patients with chronic hepatitis BJ Ultrasound Med201736226126827914175
   PubMed Web of Science ®Google Scholar
• KuemmerleNBRysmanELombardoPSLipoprotein lipase links dietary fat to solid tumor cell proliferationMol Cancer Ther201110342743621282354
   PubMed Web of Science ®Google Scholar
• Zendzian-PiotrowskaMGórskiJFatty acid binding protein (FABP)Postepy Hig Med Dosw19944867537617675734
   PubMedGoogle Scholar
• OwadaYFatty acid binding protein: localization and functional significance in the brainTohoku J Exp Med2008214321322018323691
   PubMed Web of Science ®Google Scholar
• WangYTLiuCHZhuHLFatty acid binding protein (FABP) inhibitors: a patent review (2012–2015)Expert Opin Ther Pat201626776777627109571
   PubMed Web of Science ®Google Scholar
• WangDFuLNingWPeroxisome proliferator-activated receptor δ promotes colonic inflammation and tumor growthProc Natl Acad Sci U S A2014111197084708924763687
   PubMed Web of Science ®Google Scholar
• AlshalalfaMBismarTAAlhajjRDetecting cancer outlier genes with potential rearrangement using gene expression data and biological networksAdv Bioinformatics201220123735061322811706
   PubMedGoogle Scholar
• TothPMLieberSScheerFMDesign and synthesis of highly active peroxisome proliferator-activated receptor (PPAR) β/δ inverse agonists with prolonged cellular activityChem Med Chem201611548849626864558
   PubMedGoogle Scholar
• MorganEAForootanSSAdamsonJExpression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppressionInt J Oncol200832476777518360704
   PubMed Web of Science ®Google Scholar
• MorganEKannan-ThulasiramanPNoyNInvolvement of Fatty Acid Binding Protein 5 and PPARβ/δ in Prostate Cancer Cell GrowthPPAR Res20102010
   PubMed Web of Science ®Google Scholar
• AraiMImazekiFSakaiYAnalysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2’-de-oxycytidine, in esophageal squamous cell carcinomaOncol Rep200820240541218636205
   PubMed Web of Science ®Google Scholar
• OgawaRIshiguroHKuwabaraYIdentification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysisDis Esophagus200821428829718477249
   PubMed Web of Science ®Google Scholar
• SchugTTBerryDCToshkovIAChengLNikitinAYNoyNOvercoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RARProc Natl Acad Sci U S A2008105217546755118495924
   PubMed Web of Science ®Google Scholar
• LeviLLoboGDoudMKGenetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesisCancer Res201373154770478023722546
   PubMed Web of Science ®Google Scholar
• UmaRSNareshKND’CruzAKMulherkarRBorgesAMMetastasis of squamous cell carcinoma of the oral tongue is associated with down-regulation of epidermal fatty acid binding protein (E-FABP)Oral Oncol2007431273216759896
   PubMed Web of Science ®Google Scholar
• XiaoYBCaiSHLiuLLYangXYunJPDecreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinomaCancer Manag Res2018101781178929983595
   PubMed Web of Science ®Google Scholar
• GerbensFRettenbergerGLenstraJAVeerkampJHTe PasMFCharacterization, chromosomal localization, and genetic variation of the porcine heart fatty acid-binding protein geneMamm Genome1997853283329107676
   PubMed Web of Science ®Google Scholar
• CaiSLiZYuTXiaMPengJSerum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogsInfect Drug Resist20181146947729662321
   PubMed Web of Science ®Google Scholar
• XueXCaiSComment on “Assessment of liver stiffness in pediatric fontan patients using transient elastography”Can J Gastroenterol Hepatol20162016934396028025635
   PubMedGoogle Scholar
• CaiSCaoJYuTXiaMPengJEffectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pretreated with interferon compared with de novo therapy with entecavir and telbivudineMedicine20179622e702128562554
   PubMed Web of Science ®Google Scholar
• CaiSYuTJiangYZhangYLvFPengJComparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week resultClin Exp Med201616342943626164128
   PubMed Web of Science ®Google Scholar
• MandairDSRossiREPericleousMWhyandTCaplinMThe impact of diet and nutrition in the prevention and progression of hepatocellular carcinomaExpert Rev Gastroenterol Hepatol20148436938224597926
   PubMed Web of Science ®Google Scholar
• FuruhashiMOguraMMatsumotoMSerum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophagesSci Rep20177121728303004
   PubMedGoogle Scholar
• HongJGuWZhangYDifferent association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adultsAtherosclerosis2011217119420021492859
   PubMed Web of Science ®Google Scholar
• IshimuraSFuruhashiMWatanabeYCirculating levels of fatty acid-binding protein family and metabolic phenotype in the general populationPLoS One2013811e8131824278421
   PubMed Web of Science ®Google Scholar